Position statements outline the Cancer Society's views on specific health issues.
Breakthrough therapies and the New Zealand Early Access to Medicines Scheme
It is highly unusual for the Cancer Society to get involved in any national debate around the funding of particular cancer drugs. However, in the case of the new immunotherapies for melanoma, we have made an exception for reasons of equity, evidence and deep concerns about decision processes.
Folate and Reducing Cancer Risk
Based on current evidence, the benefits of folic acid fortification for reducing the incidence of neural tube defects outweigh any potential increased risk of cancer. Therefore the Cancer Society of New Zealand and Cancer Council Australia are not opposed to fortification of foods with folic acid.